Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial.
Kaku K, Haneda M, Sakamaki H, Yasui A, Murata T, Ustyugova A, Chin R, Hirase T, Shibahara T, Hayashi N, Kansal A, Kaspers S, Okamura T.
Kaku K, et al. Among authors: kaspers s.
Clin Ther. 2019 Oct;41(10):2021-2040.e11. doi: 10.1016/j.clinthera.2019.07.016. Epub 2019 Sep 25.
Clin Ther. 2019.
PMID: 31561882
Free article.
Clinical Trial.